By David Woods ([email protected]) With healthcare in the US consuming about 16% of GNP, or around 2 trillion dollars a year, and still leaving an estimated 47 million people uninsured,…
Details
By Mary Gabb ([email protected]) The UK ‘s National Institute for Health and Clinical Excellence (NICE) has recently ruled that four drugs used to treat advanced kidney cancer are not effective…
Details
By Ruth Whittington ([email protected]) Rx Communications has just returned triumphant from the 11th annual European Congress of ISPOR. ISPOR is a great place to meet old friends, find new ones,…
Details
By Julie Stauffer ([email protected]) Pharmaceutical companies produce hundreds of life-saving drugs every year. Yet each year, millions of people in developing countries die from preventable and treatable illnesses – diseases…
Details
By Robert Hand ([email protected]) Under the title “Setting the Pace,” the American Medical Writers Association (AMWA) held its 68th Annual Conference on October 23–25 in horse country, Louisville , Kentucky…
Details
By David Woods ([email protected]) Drug company Eli Lilly has said that it will start disclosing the amounts of money over $500 that it pays to physicians – and other firms…
Details
By Mary Gabb ([email protected] ) Since 1996, DTCA has existed only in the USA and New Zealand , but recent declarations from the European Commission (EC) suggest that the rules…
Details
By Mary Gabb ([email protected] ) The publication several years ago of Selling Sickness: How the World’s Biggest Pharmaceutical Companies are Turning Us All into Patients by Ray Moynihan and Alan…
Details
The US Food and Drug Administration (FDA) in August proposed a new guideline asking the sponsors of clinical trials to submit annual development safety update reports (DSURs). The guideline, titled “E2F Development Safety Update Report,” is in draft form and describes the format, content, and timing of a DSUR.
Details
By Julie Stauffer ([email protected]) How quickly can you lay your hands on tomorrow’s meeting agenda, the latest batch of clinical data, or the draft report you’ve been asked to review?…
Details
